10-71755398-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022153.2(VSIR):c.637C>T(p.Leu213Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000151 in 1,613,402 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022153.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIR | NM_022153.2 | c.637C>T | p.Leu213Phe | missense_variant | 4/7 | ENST00000394957.8 | NP_071436.1 | |
CDH23 | NM_022124.6 | c.4845+13477G>A | intron_variant | ENST00000224721.12 | NP_071407.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIR | ENST00000394957.8 | c.637C>T | p.Leu213Phe | missense_variant | 4/7 | 1 | NM_022153.2 | ENSP00000378409 | P1 | |
CDH23 | ENST00000224721.12 | c.4845+13477G>A | intron_variant | 5 | NM_022124.6 | ENSP00000224721 | P1 | |||
VSIR | ENST00000470317.2 | n.122C>T | non_coding_transcript_exon_variant | 2/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152158Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000684 AC: 17AN: 248604Hom.: 0 AF XY: 0.0000519 AC XY: 7AN XY: 134916
GnomAD4 exome AF: 0.000150 AC: 219AN: 1461244Hom.: 0 Cov.: 33 AF XY: 0.000147 AC XY: 107AN XY: 726870
GnomAD4 genome AF: 0.000164 AC: 25AN: 152158Hom.: 1 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2021 | The c.637C>T (p.L213F) alteration is located in exon 4 (coding exon 4) of the C10orf54 gene. This alteration results from a C to T substitution at nucleotide position 637, causing the leucine (L) at amino acid position 213 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at